Trial intelligence / Profile preview

CTM Boost vs Corticosteroid for Rotator Cuff Tendinopathy

NCT06712290Withdrawn

Sponsor
Allegheny Singer Research Institute
Start
Nov 2024
Primary completion
Dec 2025
Modality
Biologic
Countries
1
01

Overview

Randomised, double-blind trial of CTM Boost in rotator cuff tendinopathy (RCT) (2 arms), sponsored by Allegheny Singer Research Institute. Primary endpoint: Western Ontario Rotator Cuff Index at 3 months. Planned start Nov 2024; status: withdrawn.

02

Drugs

CTM Boost
03

Conditions

rotator cuff tendinopathy (RCT)

Beyond the preview

Go deeper on NCT06712290.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06712290.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call